AUC Score :
Short-term Tactic1 :
Dominant Strategy :
Time series to forecast n:
ML Model Testing : Modular Neural Network (DNN Layer)
Hypothesis Testing : Statistical Hypothesis Testing
Surveillance : Major exchange and OTC
1Short-term revised.
2Time series is updated based on short-term trends.
Key Points
This exclusive content is only available to premium users.About HURA
TUH Biosci is a clinical-stage biopharmaceutical company focused on developing novel therapies for challenging diseases. The company's pipeline targets areas with significant unmet medical needs, aiming to bring innovative treatment options to patients. TUH Biosci's approach centers on leveraging cutting-edge scientific understanding to design and advance its drug candidates through rigorous clinical development. Their commitment to scientific advancement and patient well-being underpins their strategic direction and research endeavors.
TUH Biosci's core strategy involves identifying and developing therapeutic candidates with the potential to address serious medical conditions. The company is dedicated to advancing these candidates through the necessary stages of clinical trials, with the ultimate goal of seeking regulatory approval and making these treatments accessible. This focus on innovation and patient-centric development positions TUH Biosci as a participant in the ongoing pursuit of medical breakthroughs.
ML Model Testing
n:Time series to forecast
p:Price signals of HURA stock
j:Nash equilibria (Neural Network)
k:Dominated move of HURA stock holders
a:Best response for HURA target price
For further technical information as per how our model work we invite you to visit the article below:
How do KappaSignal algorithms actually work?
HURA Stock Forecast (Buy or Sell) Strategic Interaction Table
Strategic Interaction Table Legend:
X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)
Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)
Z axis (Grey to Black): *Technical Analysis%
| Rating | Short-Term | Long-Term Senior |
|---|---|---|
| Outlook | Baa2 | Baa2 |
| Income Statement | Baa2 | Baa2 |
| Balance Sheet | Baa2 | Ba2 |
| Leverage Ratios | B1 | Baa2 |
| Cash Flow | Ba3 | Baa2 |
| Rates of Return and Profitability | Baa2 | B1 |
*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?
References
- Mnih A, Kavukcuoglu K. 2013. Learning word embeddings efficiently with noise-contrastive estimation. In Advances in Neural Information Processing Systems, Vol. 26, ed. Z Ghahramani, M Welling, C Cortes, ND Lawrence, KQ Weinberger, pp. 2265–73. San Diego, CA: Neural Inf. Process. Syst. Found.
- E. Altman, K. Avrachenkov, and R. N ́u ̃nez-Queija. Perturbation analysis for denumerable Markov chains with application to queueing models. Advances in Applied Probability, pages 839–853, 2004
- E. Altman. Constrained Markov decision processes, volume 7. CRC Press, 1999
- V. Borkar and R. Jain. Risk-constrained Markov decision processes. IEEE Transaction on Automatic Control, 2014
- N. B ̈auerle and J. Ott. Markov decision processes with average-value-at-risk criteria. Mathematical Methods of Operations Research, 74(3):361–379, 2011
- V. Mnih, K. Kavukcuoglu, D. Silver, A. Rusu, J. Veness, M. Bellemare, A. Graves, M. Riedmiller, A. Fidjeland, G. Ostrovski, S. Petersen, C. Beattie, A. Sadik, I. Antonoglou, H. King, D. Kumaran, D. Wierstra, S. Legg, and D. Hassabis. Human-level control through deep reinforcement learning. Nature, 518(7540):529–533, 02 2015.
- Chen X. 2007. Large sample sieve estimation of semi-nonparametric models. In Handbook of Econometrics, Vol. 6B, ed. JJ Heckman, EE Learner, pp. 5549–632. Amsterdam: Elsevier